Servier has released its 2024/2025 Annual Report, reflecting a year marked by strong performance, collective achievements, and meaningful progress toward our Servier 2030 ambition. This year’s edition highlights the Group’s major milestones—showcasing innovation, scientific advancement, and our continued commitment to patients worldwide.
For Servier Philippines, the report resonates strongly with our ongoing transformation as we continue to strengthen our impact across cardiometabolic, venous, and neuropsychiatric care, while advancing initiatives that support improved patient outcomes in the country.
What you’ll find in this year’s report:
- Key milestones from 2025, a pivotal year in the Group’s transformation
- Our therapeutic areas and value-creation model, including the stakeholders who support our mission
- Progress in financial and non‑financial results, aligned with our 2030 objectives
- An in‑depth analysis of four major global shifts in healthcare, developed in partnership with L’ADN media:
- Innovation as an interconnected ecosystem
- The patient as a true partner in care
- The evolving geopolitics of health
- The impact of population aging on the pharmaceutical landscape
We invite you to explore the full digital report and learn more about how our global advancements guide our local commitment to Filipino patients and healthcare partners.
👉 Read the full 2024/2025 Annual Report 🔗 https://servier.com/en/newsroom/annual-report-available/
